Treatment Algorithm Overview: BoNT Therapy for Pain

Pain Practice

Volumn 4, Issue , 2004, Pages S54-S67

  Raj, P Prithvi ^a  

^a World Institute of Pain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B; PLACEBO;

ALGORITHM; ANALGESIA; ARTICLE; BLEPHAROSPASM; CERVICAL DYSTONIA; DRUG ADMINISTRATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; FACIAL NERVE DISEASE; HEADACHE; HUMAN; LOW BACK PAIN; NECK PAIN; NEUROLOGIC EXAMINATION; PATIENT ATTITUDE; SHOULDER PAIN; STRABISMUS;

EID: 18844422503     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2004.04015.x     Document Type: Article

References (13)

1. Radensky PW, Archer JW, Dournaux SF, O'Brien CF. The estimated cost of managing focal spasticity: a physician practice patterns survey. Neurorehabil Neural Repair. 2001;15: 57-68.
2. Royal MA. The use of botulinum toxins in the management of pain and headache. Pain Practice. 2001;1: 215-235.
3. ® (botulinum toxin type A) purified neurotoxin complex for the treatment of cervical dystonia. 1998.
4. Barrientos N, Chana P. Efficacy and safety of botulinum toxin type A (Botox) in the prophylactic treatment of migraine [abstract S106]. Headache. 2002;42: 452.
5. Silberstein S, Mathew N, Saper J, for the BOTOX Migraine Clinical Research Group. Botulinum toxin type A as a migraine preventive treatment. Headache. 2000;40: 445-450.
6. Freund BJ, Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study. Headache. 2000;40: 231-236.
7. Smuts JA, Baker MK, Smuts HM, Rheta Stassen JM, Rossouw E, Barnard PWA. Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol. 1999;6(suppl 4):S99-S102.
8. ®), administered using a novel injection technique, for the treatment of myofascial pain. Am J Pain Manag 2000;10: 108-112.
9. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain. 2000;85: 101-105.
10. Foster L, Clapp L, Erickson M, Jabbari B. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology. 2001;56: 1290-1293.
11. Pierson SH. Outcome measures in spasticity management. Muscle Nerve. 1997;20(suppl 6):S36-S60.
12. Raj PP, Lou L, Erdine S, Staats PS, Waldman S. Radiographic Imaging for Regional Anesthesia and Pain Management. Philadelphia, PA: Churchill Livingstone, 2003.
13. Popelianskii II, Bobrovnikoza TI. The syndrome of the piriformis muscle and lumbar discogenic radiculitis [Russian]. Zh Nevropatol Psikhiatr. 1968;68: 656-662.